White House to deploy surge teams to COVID-19 hotspots; J&J reports vaccine elicits antibodies against Delta variant
The White House plans to deploy COVID-19 surge response teams to help communities experiencing or at risk for hotspots due to the Delta variant and low vaccination with vaccination, testing, contact tracing, therapeutics and staffing, White House COVID-19 Response Coordinator Jeff Zients announced yesterday.
“These are dedicated teams working with communities at higher risk for or already experiencing outbreaks due to the spread of the Delta variant and their low vaccination rate,” Zients said.
In other news, Johnson and Johnson yesterday said its single-shot COVID-19 vaccine demonstrated strong neutralizing antibody activity against the Delta variant in blood samples from eight participants in its phase 3 clinical trial of the vaccine
Related News Articles
Headline
Centers for Medicare & Medicaid Services Administrator Mehmet Oz, M.D., and CMS Deputy Administrator and Director of Medicaid and CHIP Dan Brillman sat…
Headline
Flu and COVID-19 vaccination rates among all health care workers for the 2024-25 respiratory virus season was 76.3% and 40.2%, respectively, according to a…
Headline
A study published March 18 by Science Advances estimated that more than 155,000 U.S. COVID-19 deaths were uncounted during the COVID-19 pandemic. Researchers…
Headline
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including certain wearable devices) and the…
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…